Clinical Trials Directory

Trials / Completed

CompletedNCT05368272

EEG Spectrogram, Brain Vulnerability and POD

EEG Spectrogram to Assess Brain Vulnerability as a Risk Factor for Postoperative Delirium in Older People - a Feasibility Study

Status
Completed
Phase
Study type
Observational
Enrollment
30 (actual)
Sponsor
University of Nottingham · Academic / Other
Sex
All
Age
65 Years
Healthy volunteers
Not accepted

Summary

An assessment of difference in prespecified processed electroencephalography variables between cognitively intact older surgical patients who develop postoperative delirium compared to those who do not develop postoperative delirium

Detailed description

Postoperative delirium in older people may be contributed to by intrinsic brain vulnerability such as pre-existing dementia. Some cognitively intact older people also experience postoperative delirium and in these patients some go on to develop later dementia. The investigators propose that postoperative delirium may be an unmasking of covert brain vulnerability by the dyshomeostasis of the anaesthesia/surgical intervention. In people with dementia or mild cognitive impairment, electroencephalography (EEG) studies have shown slowing of brain wave activity, especially in the back of the brain. Processed electroencephalography, using a limited number of channels, is routinely used during anaesthesia to aid assessment of anaesthetic depth of the patient. In this study the investigators will assess the feasibility of acquiring EEG data from the front and back of the brain. The investigators will also explore the data for early signals of brain vulnerability

Conditions

Interventions

TypeNameDescription
OTHERProcessed electroencephalographyAcquisition of raw EEG data from processed EEG monitor. Analysis of data acquired for prespecified bandwidth properties
OTHERPostoperative delirium assessmentTwice daily assessment for the incidence of postoperative delirium using validated tool (questionnaire)

Timeline

Start date
2023-01-27
Primary completion
2023-12-06
Completion
2023-12-06
First posted
2022-05-10
Last updated
2024-02-28

Locations

1 site across 1 country: United Kingdom

Source: ClinicalTrials.gov record NCT05368272. Inclusion in this directory is not an endorsement.